Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
03/2005
03/24/2005WO2004041161A3 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
03/24/2005US20050065352 Process for the purification of thiophenes
03/24/2005US20050065193 Carbamates of 2-heterocyclic-1,2-ethanediols
03/24/2005US20050065139 Antidiabetic agents; controlling carbohydrate metabolism
03/24/2005US20050065095 Antibacterial agents
03/24/2005US20050065033 Method to inhibit ethylene responses in plants
03/24/2005US20050064415 Novel terthiophene-3-carboxylic acid compound and fabricating method thereof, functionalized conductive terthiophene polymer with the compound as a monomer, process for dna hybridizatioon detection using the polymer, and fabricating method of probe dna
03/23/2005EP1516877A1 Amine derivatives as protease inhibitors
03/23/2005EP1515944A1 Aspartyl protease inhibitors
03/23/2005EP1515941A1 2-naphthamide derivatives
03/23/2005EP1152764A4 Compositions and methods for use in targeting vascular destruction
03/23/2005CN1599717A Cyclic diamine compounds having fused-ring groups
03/23/2005CN1599611A Piperazine derivatives for use as CCR-3 receptor antagonists in the treatment of asthma
03/23/2005CA2482113A1 Process for the purification of thiophenes
03/22/2005US6869953 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
03/22/2005CA2257772C Bicyclic¬3.1.0|hexanes and related compounds
03/22/2005CA2225250C Bicyclic amino derivatives and pgd2 antagonist containing the same
03/17/2005WO2005023818A2 Heterobicyclic compounds as pharmaceutically active agents
03/17/2005WO2005023267A1 Cyclohexyl prostaglandin analogs as ep4-receptor agonists
03/17/2005WO2005023261A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
03/17/2005WO2004087061A3 Tubulin binding agents and corresponding prodrug constructs
03/17/2005US20050059730 Thiophene-containing compound and thiophene-containing compound polymer
03/17/2005US20050059729 Substituted cyclic compounds
03/17/2005US20050059714 2-Cyclopropyl-4-(5-fluoro-2-methoxyphenyl)-4-methyl-1-(1H-pyrrolo[2,3-c]pyridin-2-yl)pentan-2-ol; treating diseases of inflammatory, allergic, or proliferative condition; type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumor
03/17/2005US20050059712 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma
03/17/2005US20050059668 Substituted acylpiperazine derivatives
03/17/2005US20050059611 such as 3-{4-[1-(4-Cyclohex-1-enylphenyl)-3-(3,5-dichlorophenyl)ureidomethyl]benzoylamino}-2,2-difluoropropionic acid), used for treatment and/or prevention of hyperglycemia, diabetes, lipid metabolism disorders and obesity
03/17/2005DE10306502B4 Substituierte 3-(Benzoylureido)-thiophenderivate und sie enthaltende Arzneimittel Substituted 3- (Benzoylureido) -thiophenderivate and medicaments containing them
03/17/2005CA2572750A1 Heterobicyclic compounds as pharmaceutically active agents
03/17/2005CA2538135A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
03/17/2005CA2537252A1 Cyclohexyl prostaglandin analogs as ep4-receptor agonists
03/16/2005EP1513825A2 Anti tubercular drug: compositions and methods
03/16/2005EP1049664B1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
03/16/2005EP0874625B1 Indane derivatives for antipsychotic compositions
03/16/2005EP0758324B1 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
03/16/2005CN1596240A Chalcone derivatives and their use to treat diseases
03/16/2005CN1193010C Heterocyclonitrogen heteroethane derivant with antiviral activity
03/16/2005CN1193000C Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cometic compositions containing same
03/15/2005US6867310 Synthesize efficiently and under mild conditions alpha -aryl and alpha -vinyl products from a wide range of starting materials, including ketones, esters, hydrazones, and imines, enantiomorphs
03/15/2005US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency
03/15/2005US6867243 Making by photopolymerization of a reactive mesogen having a photopolymerizable endgroup, such as a diene; intermediate 2,7-bis(5-(4-hydroxyphenyl)thien-2-yl)-9,9-dipropylfluorene
03/15/2005CA2063671C Aminoguanidines
03/10/2005WO2005021527A2 Process for the asymmetric hydrogenation of beta-amino ketones
03/10/2005WO2005021525A1 Aryl piperidine amides
03/10/2005WO2005021487A1 Cathepsin inhibitors
03/10/2005WO2005021486A1 Ester derivative and medicinal use thereof
03/10/2005WO2005020897A2 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/10/2005WO2004067481A3 Improved jasmine aromachemicals
03/10/2005WO2004041802A8 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
03/10/2005US20050054860 preparing benzo[b]thiophenecarbodithioic esters from the thioate with reduced equivalents of P2S5, alkali metal carbonate and catalyst in hot toluene; non-halogenated solvents; waste reduction;
03/10/2005US20050054651 Compositions and methods for the treatment of disease associated with Trp-p8 expression
03/10/2005US20050054637 Prophylaxis, therapy cardiovascular disorders
03/10/2005US20050053861 Onium salt compound and radiation-sensitive resin composition
03/10/2005CA2536461A1 Aryl piperidine amides
03/10/2005CA2535366A1 Cathepsin inhibitors
03/10/2005CA2535265A1 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/09/2005EP1512704A1 High refractive index, UV-curable monomers and coating compositions prepared therefrom
03/09/2005EP1512678A1 Process for preparing optically active nitro compounds and cyano compounds
03/09/2005EP1511740A1 Phenyl-thiophene type vitamin d receptor modulators
03/09/2005EP1511729A1 Histone deacetylase inhibitors based on alphachalcogenmethylcarbonyl compounds
03/09/2005EP1511473A2 Bis-aromatic alkanols
03/09/2005EP1511472A2 Compounds useful in the treatment of anthrax and inhibiting lethal factor
03/09/2005EP1123918B1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same
03/09/2005CN1592735A Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives
03/09/2005CN1590372A Arylphenyl-substituted cyclic ketoenols
03/09/2005CN1590357A Lightfast additive having uv-absorbing moiety and ink composition including the same
03/08/2005US6864394 Method for producing ketones from carboxylic acid anhydrides
03/08/2005US6864392 α-Sulfin and α-Sulfonamino amide derivatives
03/08/2005US6864380 Antiinflammatory agents; asthma; antiallergens; autoimmune diseases; antiarthritic agents
03/08/2005US6864375 Thiophene derivatives; an electrooptic device such as a waveguide, switch, modulator, coupler, router, (tele)communications system, data transmission device, and a interferometric optical modulator or switch
03/08/2005US6864368 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
03/08/2005US6864263 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy
03/03/2005WO2005019210A1 Polythiophene-based sensors
03/03/2005WO2005019199A1 Amorphous duloxetine hydrochloride
03/03/2005WO2005019198A1 Acene-thiophene semiconductors
03/03/2005WO2005019194A1 Derivatives of hydroxamic acid as metalloproteinase inhibitors
03/03/2005WO2005019174A1 Acetylene derivatives as inhibitors of histone deacetylase
03/03/2005WO2005019163A2 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
03/03/2005WO2005019147A2 Pesticidally active phenol derivatives
03/03/2005WO2005000309A3 Chemical compounds
03/03/2005US20050049429 Kinase inhibitors; antiproliferative agents; anticancer agents; psoriasis; restenosis
03/03/2005US20050049376 High refractive index, uv-curable monomers and coating compositions prepared therefrom
03/03/2005US20050049325 Photopolymerization of acrylated ester
03/03/2005US20050049239 Type 2 glycine transporter inhibitors; muscle spasticity, tinnitus, epilepsy neuropathic pain, obesity
03/03/2005US20050049227 Cyclohexyl prostaglandin analogs as EP4-receptor agonists
03/03/2005CA2535350A1 Acetylene derivatives as inhibitors of histone deacetylase
03/02/2005EP1510517A1 Process for the asymmetric hydrogenation of beta-amino ketones
03/02/2005EP1509530A1 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
03/02/2005EP1509514A1 Anthelmintic and insecticidal thiophene derivatives
03/02/2005EP1509509A1 Glucagon antagonists/inverse agonists
03/02/2005EP1509497A1 Calcium receptor modulating arylalkylamines
03/02/2005EP1509221A1 N-acylaminoacetonitrile derivatives and their use for controlling parasites
03/02/2005EP1278741B1 Muscarinic agonists
03/02/2005EP1042279B1 Substituted beta-alanines
03/02/2005EP0991636B1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
03/02/2005CN1589153A Preventives/remedies for urinary disturbance
03/02/2005CN1191243C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
03/02/2005CN1191232C Aminomethylcarboxylic acid derivatives
03/02/2005CN1191063C Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders
03/01/2005US6861496 Polyhydroxyalkonoate and method of producing same, and ω-(2-thienylsulfanyl) alkanoic acid and method of producing same